Home » Pharma News » CyMedica Orthopedics gets US FDA nod for e-vive wireless muscle stimulation device for knee surgery rehabilitation

CyMedica Orthopedics gets US FDA nod for e-vive wireless muscle stimulation device for knee surgery rehabilitation

CyMedica Orthopedics gets US FDA nod for e-vive wireless muscle stimulation device for knee surgery rehabilitation

CyMedica Orthopedics, a developer and manufacturer of innovative muscle rehabilitation systems, has announced US Food and Drug Administration (FDA) clearance for e-vive- the first of its kind app-controlled, data-driven muscle activation therapy and patient engagement solution designed to empower at-home pre-hab to rehab muscle strengthening for ACL and total knee replacement patients.

The innovative e-vive wireless muscle stimulation device was designed to address the problems associated with muscle atrophy where patients can lose over 60 per cent of their quad strength after knee surgery. Post surgical muscle atrophy can cost up to $4,200 per episode due to additional rehabilitation, and a higher likelihood of readmissions.

Read more @ http://www.pharmabiz.com/NewsDetails.aspx?aid=99882&sid=2

Thanks for the comment

BIGTheme.net • Free Website Templates - Downlaod Full Themes
Social Media Auto Publish Powered By : XYZScripts.com